Accès à distance ? S'identifier sur le proxy UCLouvain
Radezolid (RX-1741), a novel oxazolidinone, accumulates extensively within human macrophages and PMNs and shows activity towards intracellular linezolid-sensitive and linezolid-resistant Staphylococcus aureus
Primary tabs
Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
---|---|
Access type | Accès restreint |
Publication date | 2009 |
Language | Anglais |
Conference | "26th International Congress of Chemotherapy and Infection", Toronto(Canada) (Jun 18-21, 2009) |
Journal information | "International Journal of Antimicrobial Agents" - Vol. 34, p. S12 (2009) |
Peer reviewed | yes |
issn | 0924-8579 |
e-issn | 1872-7913 |
Publisher | Elsevier Science Bv (Amsterdam) |
Affiliation | UCL - MD/FARM - Ecole de pharmacie |
Links |
Bibliographic reference | Lemaire, Sandrine ; Kosowska-Shick, K. ; Appelbaum, P. ; Tulkens, Paul M. ; Van Bambeke, Françoise. Radezolid (RX-1741), a novel oxazolidinone, accumulates extensively within human macrophages and PMNs and shows activity towards intracellular linezolid-sensitive and linezolid-resistant Staphylococcus aureus.26th International Congress of Chemotherapy and Infection (Toronto(Canada), Jun 18-21, 2009). In: International Journal of Antimicrobial Agents, Vol. 34, p. S12 (2009) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/58923 |